Clinical Laserthermia Systems AB (publ)

DB:LS60 Stock Report

Market Cap: €5.3m

Clinical Laserthermia Systems Balance Sheet Health

Financial Health criteria checks 4/6

Clinical Laserthermia Systems has a total shareholder equity of SEK58.2M and total debt of SEK1.2M, which brings its debt-to-equity ratio to 2%. Its total assets and total liabilities are SEK68.5M and SEK10.3M respectively.

Key information

2.0%

Debt to equity ratio

SEK 1.19m

Debt

Interest coverage ration/a
CashSEK 15.58m
EquitySEK 58.20m
Total liabilitiesSEK 10.28m
Total assetsSEK 68.49m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: LS60's short term assets (SEK31.3M) exceed its short term liabilities (SEK10.1M).

Long Term Liabilities: LS60's short term assets (SEK31.3M) exceed its long term liabilities (SEK223.0K).


Debt to Equity History and Analysis

Debt Level: LS60 has more cash than its total debt.

Reducing Debt: LS60's debt to equity ratio has reduced from 99.6% to 2% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: LS60 has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: LS60 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12.5% each year


Discover healthy companies